UnknownNCT06039436

Conditioning Regimen Containing Low Dose ATG for The Treatment of Acquired SAA Receiving sUCBT

Studying Aplastic Anemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Anhui Provincial Hospital
Principal Investigator
Xiaoyu Zhu, ph.D
The First Affiliated Hospital of University of Science and Technology of China (Anhui Provicial Hospital)
Intervention
Anti-Thymocyte Globulin (Rabbit)(drug)
Enrollment
72 enrolled
Eligibility
1-50 years · All sexes
Timeline
20232025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06039436 on ClinicalTrials.gov

Other trials for Aplastic Anemia

Additional recruiting or active studies for the same condition.

See all trials for Aplastic Anemia

← Back to all trials